{
  "version": "1.0",
  "priority_threshold": 0.6,
  "keywords": [
    "21 CFR Part 11",
    "Annex 11",
    "ALCOA+",
    "CSV",
    "CSA",
    "process validation",
    "cleaning validation",
    "equipment qualification",
    "deviation",
    "CAPA",
    "audit trail",
    "eTMF",
    "PSUR",
    "PBRER",
    "QMS",
    "LIMS",
    "MES",
    "eQMS",
    "ELN",
    "GxP cloud",
    "warning letter",
    "483",
    "inspection",
    "GMP",
    "GCP",
    "GLP",
    "GVP"
  ],
  "auto_assign": {
    "regulatory": "CCO",
    "competitive": "CRO",
    "market": "CEO",
    "technology": "COO"
  },
  "feeds": [
    "https://www.biospace.com/rss/",
    "https://www.bioworld.com/rss.xml",
    "https://www.fiercepharma.com/rss/xml",
    "https://www.fiercebiotech.com/rss/xml"
  ]
}